personalized medicine

State of play The aim of Europe’s policies and actions in public health is to improve and protect human health, and to support the modernisation of Europe's health systems - which the EU sees both as improving the quality of its citizens' lives, and as a contribution to goals involving growth and jobs. While the responsibility for health lies principally at the level of individual Member States, EU institutions have an important role in promoting, coordinating and complementing national actions and in driving collaboration and cooperation. The Commission's key role is to support Member States' efforts to protect and improve the health of their citizens and to ensure the accessibility, effectiveness and resilience of their health systems. Work by proponents of personalised medicine has, in recent years, laid the foundation for bringing an advanced personalised healthcare approach into effect in a realistic timeframe. Leverage among the many distinct stakeholders across the complex context of personalised healthcare has opened up new possibilities for sophisticated engagement and imminent tangible change. Such activity undertaken by the European Alliance for Personalised Medicine has complemented, reinforced and influenced European thinking and the need for reinforcement is evident. A future in view A new approach towards personalised medicine can bring major benefits by the end of the next legislature, by fully exploiting the potential of personalised health with a new vision of coherent strategies based around prevention, early detection, and treatment. This will mean making optimal use of Big Data's ability to modify what is possible in medical research and patient care. It will depend on more effective leverage of new technologies, to sharpen the impact of R&D on early diagnostics. It will mobilise diagnostics to guarantee patient access to personalised healthcare. And closer collaboration between authorities involved will ease the demonstration of the value of...